PDCD1 and hepatocellular carcinoma: This work revises the types of HCC potentially sensitive to immunotherapy, the role of PD-1 expressing CD8 T cells in HCC treatment, the target population for CD8 T cell immunotherapy and the effect of PD-1 based treatment combinations on the restauration of HCC-specific cytotoxic T cell response.